Background/Purpose: The spread of the novel Coronavirus (SARS-CoV-2) has caused
major problems for cancer screening services around the world. This has led to
delayed diagnoses, more advanced stages of cancer at diagnosis, and an expected
increase in cancer deaths. This review looks at how the pandemic has affected
cancer screening around the world. It also looks at how people are recovering and
what new treatments and policies are being used to get more people screened.
Methods: A thorough search was done on PubMed, Scopus, and Google Scholar.
Also, the keywords included "breast/cervical/colorectal cancer testing" and "COVD-
19." The article contains articles published between January 2019 and June 2025. The
articles published between 2021 and 2025 were given priority. Thirteen studies met
the requirements for inclusion in this review. Results: At the start of the pandemic,
there were big decreases in cancer screenings. For different cancers and places,
reductions of 50-94% were seen. The cuts were especially bad for screenings for
cervical and breast cancer. The recovery was uneven. Guidelines were more often
followed in high-income countries by 2021–2022, however, low- and middle-income
countries (LMICs) continued to face significant challenges until 2023. Disparities in
guideline adherence worsened along racial, economic, and geographic lines. After
the pandemic, people were more likely to continue following the rules if they were
taught new ways to do so or given support through telehealth. Originality: The
review analyses cancer screening disruptions and recovery (2019-25) in high-,
middle- and low-income health systems.
Keywords: cancer screening, COVID-19 pandemic, screening adherence, breast
cancer, colorectal cancer, cervical cancer, health disparities, global oncology
